SLDB
Solid Biosciences Inc.NASDAQHealthcare$7.49+3.34%ClosedMarket Cap: $583.5M
As of 2026-04-06
Analyst Consensus
Consensus
Buy
Target (Consensus)
$12.50
Target (Median)
$12.50
Target Range
$9.00 - $16.00
Upside from current price: 66.9%
Rating Distribution
4 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-25 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-20 | Needham | maintain | Buy | Buy |
| 2026-03-20 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-12 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-09 | Needham | maintain | Buy | Buy |
| 2025-11-05 | Citigroup | maintain | Buy | Buy |
| 2025-11-05 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-04 | Barclays | maintain | Overweight | Overweight |
| 2025-11-04 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.68 | $19.0M | 9 |
| Sun Dec 31 | $-0.96 | $107.0M | 6 |
| Mon Dec 31 | $0.15 | $279.6M | 4 |
| Tue Dec 31 | $1.17 | $456.3M | 2 |